← All companies
Cullinan Therapeutics, Inc.
CGEM - Company ID 0001789972
Market cap$1.12 B
Rank#2570
Filings435
The table below shows Cullinan Therapeutics, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $88.33M | $83.00M | $98.43M | $156.15M | $59.77M |
| Short-term investments | $289.56M | $315.97M | $368.63M | $311.14M | $230.69M |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $386.76M | $414.67M | $480.19M | $474.47M | $296.56M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.